US · EHAB
Enhabit, Inc.
- Sector
- Healthcare · Medical - Care Facilities
- Headquarters
- Dallas, TX 75206
- Website
- ehab.com
Price · as of 2024-12-31
$13.75
Market cap 689.9M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $25.80 | +87.64% |
| Intrinsic Value(DCF) | $3.41 | -75.2% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $0.00 | $302.46 | |||
| 2022 | $14.00 | $94.97 | $0.00 | $0.00 | $0.00 |
| 2023 | $10.34 | $32.65 | $0.00 | $0.00 | $0.00 |
| 2024 | $8.53 | $25.80 | $0.00 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Enhabit, Inc.'s (EHAB) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $25.80
- Current price
- $13.75
- AI upside
- +87.64%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$3.41
-75.2% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| EHAB | Enhabit, Inc. | $13.75 | 689.9M | +88% | -75% | — | — | -2.78 | 0.82 | 0.41 | -11.59 | -2.98 | -0.99 | 48.71% | -11.12% | -15.09% | -25.81% | -9.68% | -11.58% | 1.09 | -2.68 | 1.53 | 1.41 | -6.47 | 9317.00% | -110.00% | 557.00% | 11.07% | 0.41 | 4.09% | 0.00% | 0.00% | 9.71% | -8.42 | 20.45 | 0.94 | 1.09 |
| AGL | Agilon Health, Inc. | $0.59 | 244.31M | +3,319% | +1,042% | — | — | -0.65 | 2.01 | 0.04 | 0.03 | -1.17 | 4.18 | -3.18% | -7.10% | -6.83% | -130.95% | 2821.09% | -26.04% | 0.15 | -63.41 | 1.02 | 0.89 | 0.42 | 5556.00% | -211.00% | 6755.00% | -46.67% | -0.10 | 797.30% | 0.00% | 0.00% | 2.97% | 0.03 | 0.09 | 0.00 | 1.55 |
| AUNA | Auna S.A. | $5.34 | 395.39M | +191% | +579% | -79% | +93% | 15.62 | 1.31 | 0.44 | 5.78 | — | -1.64 | 37.18% | 16.08% | 2.51% | 8.43% | 9.59% | 1.68% | 2.55 | 1.46 | 0.88 | 0.67 | 3.81 | -12820.00% | 1447.00% | 3844.00% | 29.83% | 0.34 | 11.60% | 0.06% | 0.90% | 7.63% | 7.58 | 9.29 | 1.22 | 1.07 |
| AUTL | Autolus Therapeutics plc | $1.71 | 455.11M | +3,826% | -33% | — | — | -2.32 | 1.20 | 50.68 | 0.10 | — | 1.24 | -1293.48% | -2385.63% | -2180.45% | -81.91% | 263.57% | -38.11% | 0.12 | -25.98 | 10.88 | 10.47 | 0.75 | -2750.00% | 49600.00% | 5398.00% | -47.01% | -3.40 | 263.21% | 0.00% | 0.00% | 0.00% | 0.09 | 0.09 | -2.23 | -1.19 |
| CBLL | CeriBell, Inc. | $18.67 | 692.58M | +73% | +350% | — | — | -12.42 | 3.80 | 7.45 | -10.25 | — | 3.82 | 87.89% | -65.57% | -59.97% | -29.21% | -202.59% | -25.36% | 0.14 | -30.90 | 9.73 | 9.08 | 0.33 | -5693.00% | 3609.00% | 1427.00% | -6.27% | -2.13 | -144.22% | 0.00% | 0.00% | 0.00% | -9.04 | -12.70 | 5.93 | 17.63 |
| CCRN | Cross Country Healthcare,… | $8.70 | 285.01M | +464% | -27% | -27% | +19% | -36.53 | 1.27 | 0.40 | 27.06 | — | 2.20 | 20.41% | -1.25% | -1.08% | -3.26% | -3.73% | -2.29% | 0.01 | -7.71 | 2.78 | 2.70 | -4.64 | -12146.00% | -3346.00% | -5250.00% | 20.95% | 1.00 | 27.75% | 0.00% | 0.00% | 19.42% | -26.92 | 4.08 | 0.34 | 5.01 |
| KIDS | OrthoPediatrics Corp. | $19.17 | 480.73M | +230% | -49% | -91% | — | -11.37 | 1.30 | 1.91 | -55.63 | -373.01 | 2.61 | 73.05% | -12.27% | -16.78% | -11.31% | -8.28% | -8.08% | 0.14 | -4.84 | 5.55 | 2.48 | -3.66 | 305.00% | 1545.00% | -6136.00% | -3.54% | -0.11 | -4.56% | 0.00% | 0.00% | 1.84% | -15.12 | -27.47 | 1.85 | 2.35 |
| LAB | Standard BioTools Inc. | $1.13 | 434.56M | +2,535% | -50% | -88% | +606% | -5.60 | 0.99 | 4.92 | -2.77 | — | 0.99 | 49.86% | -109.34% | -87.77% | -16.72% | -23.68% | -12.69% | 0.07 | -3588.65 | 4.19 | 1.86 | 0.92 | -6154.00% | -5108.00% | -4555.00% | -19.69% | -0.69 | -34.48% | 0.00% | 0.00% | 0.00% | -2.82 | -3.18 | 3.08 | 2.09 |
| QSI | Quantum-Si incorporated | $0.96 | 187.03M | +4,402% | -8% | — | — | -1.83 | 0.86 | 60.41 | 0.11 | -41.45 | 0.86 | 52.32% | -3550.56% | -3303.04% | -41.48% | -452.86% | -36.99% | 0.06 | — | 11.99 | 11.60 | 0.35 | 441.00% | 18262.00% | -698.00% | -50.01% | -4.83 | -385.30% | 0.00% | 0.00% | 0.00% | 0.11 | 0.13 | -3.90 | -0.42 |
| SNDA | Sonida Senior Living, Inc… | $35.89 | 673.64M | +237% | +24% | -86% | — | -105.95 | 2.82 | 1.14 | 12.59 | — | 3.53 | 89.12% | -4.87% | -0.68% | -11.61% | -2.25% | -0.45% | 5.29 | -0.40 | 0.85 | 0.48 | 8.13 | -8597.00% | 1919.00% | 27150.00% | -7.76% | -0.02 | -4.10% | 0.81% | -85.90% | 0.81% | -66.20 | -36.43 | 3.23 | -0.12 |
| TOI | The Oncology Institute, I… | $2.89 | 284.32M | +772% | +1,754% | — | — | -1.01 | 14.97 | 0.14 | -2.36 | — | -2.91 | 13.73% | -15.28% | -16.44% | -174.89% | -70.35% | -27.75% | 34.31 | -8.02 | 2.15 | 1.88 | -1.37 | -2283.00% | 2133.00% | -2582.00% | -56.44% | -0.51 | -35.49% | 0.00% | 0.00% | 23.64% | -2.12 | -4.19 | 0.32 | 0.03 |
About Enhabit, Inc.
Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
- CEO
- Barbara Ann Jacobsmeyer
- Employees
- 10.6K
- Beta
- 1.27
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($3.41 ÷ $13.75) − 1 = -75.2% (DCF, example).